syringopicroside has been researched along with Hepatitis B in 1 studies
*Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, JJ; Li, MC; Zhang, XW | 1 |
1 other study(ies) available for syringopicroside and Hepatitis B
| Article | Year |
|---|---|
Effect of Hepatocyte Targeting Nanopreparation Syringopicroside on Duck Hepatitis B Virus and Evaluation of Its Safety.
Topics: Animals; DNA, Viral; Glycosides; Hep G2 Cells; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B Virus, Duck; Humans; Mice; Mice, Inbred ICR; Virus Replication | 2022 |